-
Facts and Stats
Breast Cancer Survival Rates Continue to RiseNew report highlights decades of progress, as well as a persisting disparity.
by Thomas Celona
-
Survivor Profile
An Inspiration to OthersKay Kays, a 30-year pancreatic cancer survivor, works to advance research and raise awareness of the disease.
by Lindsey Konkel Neabore
-
Forward Look
Immunotherapy for Early-stage Lung CancerImmune checkpoint inhibitors can reduce the risk of recurrence for early-stage non-small cell lung cancer, but researchers are still exploring optimal timing for patients who have surgery.
by Anna Napolitano
-
Forward Look
The Late Effects of Childhood CancerAlmost all childhood cancer survivors will develop significant health problems related to their treatment by age 45.
by Suzanne McBride
-
Forward Look
AI Tool Could Improve Brain Tumor SurgeryAn advanced artificial intelligence tool helps surgeons accurately diagnose pediatric brain tumors during surgery.
by Carolyn Bernhardt
-
Forward Look
Non-surgical Options in Bladder CancerSome people with muscle-invasive cancer can forgo bladder removal surgery.
by Darcy Lewis
-
From the Editor-in-Chief
Early-onset Colorectal Cancer on the RiseResearchers search for reasons for the growing number of cases in people under 50.
by William G. Nelson, MD, PhD
-
Empowering Pediatric Cancer PatientsAfter twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
-
Light at the End of the Tunnel for ASPS PatientsImmunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose
-
CAR T-cell Therapy: Understanding the Warning and the RisksThe FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
